Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016 (2016), Article ID 7380439, 12 pages
http://dx.doi.org/10.1155/2016/7380439
Research Article

Ex Vivo Stromal Cell-Derived Factor 1-Mediated Differentiation of Mouse Bone Marrow Mesenchymal Stem Cells into Hepatocytes Is Enhanced by Chinese Medicine Yiguanjian Drug-Containing Serum

1Department of Infectious Disease, The First Affiliated Hospital of Dalian Medical University, No. 222, Zhongshan Road, Xigang District, Dalian 116011, China
2Department of Digestive Disease, Gansu Provincial Hospital, Lanzhou 730000, China
3Department of Chinese Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
4Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China

Received 29 December 2015; Revised 4 March 2016; Accepted 23 March 2016

Academic Editor: Yuewen Gong

Copyright © 2016 Linlin Fu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Iredale, “Cirrhosis, new research provides a basis for rational and targeted treatments,” The British Medical Journal, vol. 327, no. 7407, pp. 143–147, 2003. View at Publisher · View at Google Scholar
  2. D. S. Lee, W. H. Gil, H. H. Lee et al., “Factors affecting graft survival after living donor liver transplantation,” Transplantation Proceedings, vol. 36, no. 8, pp. 2255–2256, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M.-E. M. Amer, S. Z. El-Sayed, W. A. El-Kheir et al., “Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells,” European Journal of Gastroenterology and Hepatology, vol. 23, no. 10, pp. 936–941, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. El-Ansary, I. Abdel-Aziz, S. Mogawer et al., “Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis,” Stem Cell Reviews and Reports, vol. 8, no. 3, pp. 972–981, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. O. Jang, Y. J. Kim, S. K. Baik et al., “Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study,” Liver International, vol. 34, no. 1, pp. 33–41, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Kharaziha, P. M. Hellström, B. Noorinayer et al., “Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial,” European Journal of Gastroenterology and Hepatology, vol. 21, no. 10, pp. 1199–1205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Mohamadnejad, K. Alimoghaddam, M. Mohyeddin-Bonab et al., “Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis,” Archives of Iranian Medicine, vol. 10, no. 4, pp. 459–466, 2007. View at Google Scholar · View at Scopus
  8. M. Mohamadnejad, M. Namiri, M. Bagheri et al., “Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis,” World Journal of Gastroenterology, vol. 13, no. 24, pp. 3359–3363, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Mohamadnejad, K. Alimoghaddam, M. Bagheri et al., “Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis,” Liver International, vol. 33, no. 10, pp. 1490–1496, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C.-H. Park, S. H. Bae, H. Y. Kim et al., “A pilot study of autologous CD34-depleted bone marrow mononuclear cell transplantation via the hepatic artery in five patients with liver failure,” Cytotherapy, vol. 15, no. 12, pp. 1571–1579, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Terai, T. Ishikawa, K. Omori et al., “Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy,” Stem Cells, vol. 24, no. 10, pp. 2292–2298, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. L.-J. Dai, H. Y. Li, L.-X. Guan, G. Ritchie, and J. X. Zhou, “The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis,” Stem Cell Research, vol. 2, no. 1, pp. 16–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. X.-Q. Kang, W.-J. Zang, T.-S. Song et al., “Rat bone marrow mesenchymal stem cells differentiate into hepatocytes in vitro,” World Journal of Gastroenterology, vol. 11, no. 22, pp. 3479–3484, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. X.-L. Shi, Y.-D. Qiu, X.-Y. Wu et al., “In vitro differentiation of mouse bone marrow mononuclear cells into hepatocyte-like cells,” Hepatology Research, vol. 31, no. 4, pp. 223–231, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Lin, J. Lin, L. Bo, P. Weidong, S. Chen, and R. Xu, “Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells in an alginate scaffold,” Cell Proliferation, vol. 43, no. 5, pp. 427–434, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Oyagi, M. Hirose, M. Kojima et al., “Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats,” Journal of Hepatology, vol. 44, no. 4, pp. 742–748, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Snykers, J. De Kock, V. Tamara, and V. Rogiers, “Hepatic differentiation of mesenchymal stem cells: in vitro strategies,” Methods in Molecular Biology, vol. 698, pp. 305–314, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. P. Wang, J. H. Wang, Z. P. Yan et al., “Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF induction,” Biochemical and Biophysical Research Communications, vol. 320, no. 3, pp. 712–716, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Bhakta, P. Hong, and O. Koc, “The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation,” Cardiovascular Revascularization Medicine, vol. 7, no. 1, pp. 19–24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Matsuda-Hashii, K. Takai, H. Ohta et al., “Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1α, and stem cell factor,” Experimental Hematology, vol. 32, no. 10, pp. 955–961, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Petit, D. Jin, and S. Rafii, “The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis,” Trends in Immunology, vol. 28, no. 7, pp. 299–307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Chen, J.-Y. Chen, Y.-T. Tung et al., “High-frequency ultrasound imaging to evaluate liver fibrosis progression in rats and yi guan jian herbal therapeutic effects,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 302325, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Gou, Q. Tao, Q. Feng et al., “Urine metabolic profile changes of CCl4-liver fibrosis in rats and intervention effects of Yi Guan Jian Decoction using metabonomic approach,” BMC Complementary and Alternative Medicine, vol. 13, article 123, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. H.-J. Lin, J.-Y. Chen, C.-F. Lin et al., “Hepatoprotective effects of Yi Guan Jian, an herbal medicine, in rats with dimethylnitrosamine-induced liver fibrosis,” Journal of Ethnopharmacology, vol. 134, no. 3, pp. 953–960, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. H. J. Lin, C. P. Tseng, C. F. Lin et al., “A Chinese herbal decoction, modified Yi Guan Jian, induces apoptosis in hepatic stellate cells through an ROS-mediated mitochondrial/caspase pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 459531, 8 pages, 2011. View at Publisher · View at Google Scholar
  26. X.-L. Wang, D.-W. Jia, H.-Y. Liu et al., “Effect of Yiguanjian decoction on cell differentiation and proliferation in CCl4-treated mice,” World Journal of Gastroenterology, vol. 18, no. 25, pp. 3235–3249, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. J. Friedenstein, R. K. Chailakhyan, and U. V. Gerasimov, “Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers,” Cell and Tissue Kinetics, vol. 20, no. 3, pp. 263–272, 1987. View at Google Scholar · View at Scopus
  28. H. Zhu, Z.-K. Guo, X.-X. Jiang et al., “A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone,” Nature Protocols, vol. 5, no. 3, pp. 550–560, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Kuang, “Regulation of different concentrations of hepatocyte growth factor and fibroblast growth factor on rat liver stem cell proliferation,” International Journal of Pathology and Clinical Medicine, vol. 30, pp. 106–109, 2010. View at Google Scholar
  30. L. Zeng, L. Yang, and J. Yuan, “Experimental study of HGF, EGF effect on proliferation of cultured rat hepatocytes in vitro,” Laboratory Animal and Comparative Medicine, vol. 29, pp. 361–364, 2009. View at Google Scholar
  31. P. Ding, Z. Feng, and Z. Yang, “In vitro study of the migration of marrow stromal cells induced by SDF-1,” Chinese Journal of Neuromedicine, vol. 6, pp. 225–227, 2007. View at Google Scholar
  32. D. Kong, N. Gao, and Y. Zhang, “Migration experiment in vitro of bone marrow mesenchymal stem cells by CXCR4 gene modification,” Journal of Biomedical Engineering, vol. 26, pp. 595–600, 2009. View at Google Scholar
  33. C. Lange, P. Bassler, M. V. Lioznov et al., “Liver-specific gene expression in mesenchymal stem cells is induced by liver cells,” World Journal of Gastroenterology, vol. 11, no. 29, pp. 4497–4504, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Li, Z. Zhao, J. Liu et al., “MEK/ERK and p38 MAPK regulate chondrogenesis of rat bone marrow mesenchymal stem cells through delicate interaction with TGF-β1/Smads pathway,” Cell Proliferation, vol. 43, no. 4, pp. 333–343, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Peng, G. Zhou, K. D. K. Luk et al., “Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway,” Cellular Physiology and Biochemistry, vol. 23, no. 1–3, pp. 165–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Zhou, S. Lechpammer, J. S. Greenberger, and J. Glowacki, “Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires transforming growth factor-β/Smad3 signaling,” Journal of Biological Chemistry, vol. 280, no. 24, pp. 22688–22696, 2005. View at Publisher · View at Google Scholar · View at Scopus